Back
Fossil Group Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
46
FOSL
Fossil Group
Last Price:
0.96
Seasonality Move:
4.97%
Buy
68
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
42.92
Seasonality Move:
-13.76%
Sell
46
Fossil Group (FOSL)
is a Sell
Is Fossil Group a Buy, Sell or Hold?
- The current Fossil Group [FOSL] share price is $0.92. The Score for FOSL is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- FOSL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $43.77. The Score for CRBP is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FOSL Stock Price Chart
What is Fossil Group's stock price today?
-
The Fossil Group share price today is $0.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOSL is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $43.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
FOSL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 52.3 | Buy |
| Chaikin Money Flow: | -190757 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 0.96) | Buy |
| Bollinger Bands (100): | (0.87 - 1.31) | Sell |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 65.11 | Buy |
| Chaikin Money Flow: | 587256 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.06 - 41.02) | Buy |
| Bollinger Bands (100): | (12.92 - 40.62) | Buy |
FOSL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.92 | Buy |
| 20-day SMA: | 0.86 | Buy |
| 50-day SMA: | 0.91 | Buy |
| 200-day SMA: | 1.45 | Sell |
| 8-day EMA: | 0.93 | Sell |
| 20-day EMA: | 0.9 | Buy |
| 50-day EMA: | 0.94 | Sell |
| 200-day EMA: | 1.57 | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.49 | Buy |
| 20-day SMA: | 38.39 | Buy |
| 50-day SMA: | 38.68 | Buy |
| 200-day SMA: | 16.37 | Buy |
| 8-day EMA: | 40.1 | Buy |
| 20-day EMA: | 38.75 | Buy |
| 50-day EMA: | 35.78 | Buy |
| 200-day EMA: | 21.45 | Buy |
Fossil Group Earnings Growth & FOSL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.48 per share, an increase this year of $5.00 per share, and an increase next year of $0.06 per share.
Fossil Group Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||